Cargando…
Positional isomerism markedly affects the growth inhibition of colon cancer cells by NOSH-aspirin: COX inhibition and modeling()
We recently reported the synthesis of NOSH-aspirin, a novel hybrid that releases both nitric oxide (NO) and hydrogen sulfide (H(2)S). In NOSH-aspirin, the two moieties that release NO and H(2)S are covalently linked at the 1, 2 positions of acetyl salicylic acid, i.e. ortho-NOSH-aspirin (o-NOSH-aspi...
Autores principales: | Vannini, Federica, Chattopadhyay, Mitali, Kodela, Ravinder, Rao, Praveen P.N., Kashfi, Khosrow |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4556775/ https://www.ncbi.nlm.nih.gov/pubmed/26319435 http://dx.doi.org/10.1016/j.redox.2015.08.014 |
Ejemplares similares
-
NOSH-sulindac (AVT-18A) is a novel nitric oxide- and hydrogen sulfide-releasing hybrid that is gastrointestinal safe and has potent anti-inflammatory, analgesic, antipyretic, anti-platelet, and anti-cancer properties
por: Kashfi, Khosrow, et al.
Publicado: (2015) -
Gastrointestinal safety, chemotherapeutic potential, and classic pharmacological profile of NOSH‐naproxen (AVT‐219) a dual NO‐ and H(2)S‐releasing hybrid
por: Chattopadhyay, Mitali, et al.
Publicado: (2016) -
Hydrogen sulfide-releasing naproxen suppresses colon cancer cell growth and inhibits NF-κB signaling
por: Kodela, Ravinder, et al.
Publicado: (2015) -
Nitric Oxide-Releasing Aspirin Suppresses NF-κB Signaling in Estrogen Receptor Negative Breast Cancer Cells in Vitro and in Vivo
por: Nath, Niharika, et al.
Publicado: (2015) -
NOSH-aspirin (NBS-1120), a dual nitric oxide and hydrogen sulfide-releasing hybrid, reduces inflammatory pain
por: Fonseca, Miriam D, et al.
Publicado: (2015)